IE831563L - Penicillins - Google Patents

Penicillins

Info

Publication number
IE831563L
IE831563L IE831563A IE156383A IE831563L IE 831563 L IE831563 L IE 831563L IE 831563 A IE831563 A IE 831563A IE 156383 A IE156383 A IE 156383A IE 831563 L IE831563 L IE 831563L
Authority
IE
Ireland
Prior art keywords
formula
compound
substituent
methane
salts
Prior art date
Application number
IE831563A
Other versions
IE49893B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/039,539 external-priority patent/US4244951A/en
Application filed by Pfizer filed Critical Pfizer
Publication of IE831563L publication Critical patent/IE831563L/en
Publication of IE49893B1 publication Critical patent/IE49893B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

The present invention relates to new penicillanic acid derivatives. In particular, the present invention relates to a compound having the formula 0. .0 .ch: y—N -0-CH-.-X (I) wherein X is selected from alkylsulfonyloxy having from one to four carbon atoms in the alkyl group, benzenesulfonyloxy and toluenesulfonyloxy.
The compounds of the present invention are useful as intermediates in the preparation of methanediol bi-10 esters having the formula and pharmaceutically-acceptable salts thereof wherein R^" is selected from 2-phenylacetyl, 2-phenoxyacetyl, 2-carboxy-2-(2-thienyl)acetyl, 2-(4-ethyl-2,3-dioxopipera-5 zinocarbonylamino)-2-phenylacetyl and a group of the formula Or4- p c=o I N c >- ^ N wherein R3 is selected from hydrogen, 2-4C alkanoyl and 1-3C alkylsulfony1, which compounds are valuable antibacterial agents and form the subject of Patent Specification No.
This invention relates to derivatives of penicilla- nic acid, which is represented by the following structural formula h In formula II, broken line attachment of a substituent to 10 the bicyclic nucleus indicates that the substituent is below the plane of the bicyclic nucleus. Such a substituent is said to be in the alpha-configuration. Conversely, solid line attachment of a substituent to the bicyclic nucleus indicates that the substituent is attached above the plane 15 of the nucleus. This latter configuration is referred to as the beta-configuration.
The compounds of formula I can be prepared by reacting a compound of the formula wherein M is a carboxylate-salt forming cation with a compound of the formula X-CHj-Y, wherein X and Y are each alkylsulfonyloxy having one to four carbons in the alkyl group, benzenesulfonyloxy or toluenesulfonyloxy. A variety 5 of cations can be used to form the carboxylate salt but salts which are commonly used include: alkali metal salts, such as sodium and potassium salts; alkaline earth metal salts, such as calcium and barium salts; and tertiary amine salts, such as trimethylamine, triethylamine, tributylamine, 10 diisopropylethylamine, N-methylmorpholine, N-methylpiperid-ine, N-methylpyrrolidine, N,N'-dimethyl-piperazine and 1,2, 3,4-tetrahydroquinoline.
The reaction between the compounds above is usually carried out by contacting the reagents in a polar, organic 15 solvent, at a temperature in the range from about 0° to about 80°C., and preferably from 25° to 50°C. The compounds can be contacted in substantially equimolar proportions, but preferably the compound X-CHj-Y is used as an excess (e.g. a fourfold excess). A wi de variety of solvents can be used, 20 but it is usually advantageous to use a relatively polar solvent, since this has the effect of speeding up the reaction. Typical solvents which can be used include N,N-di-methylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethylsulfoxide and hexamethylphosphoramide. The reaction 25 time varies according to a number of factors, but at about 25°C. reaction times of several hours, e.g. 12 to 24 hours, are commonly used.
EXAMPLE 1 Methylsulfonyloxymethyl Penicillanate 1,1-Dioxide To a stirred solution of 24 g. of penicillanic acid, 1,1 -dioxide in 125 ml. of N,N-dimethylformamide is added 9.5 ml. of diisopropylethylamine, followed by 67.1 g. of di(methylsulfonyloxy)methane. Stirring is continued overnight and then the reaction mixture is added to 300 ml. of water. The pH is adjusted to 6.5, and then the mixture is extracted with ethyl acetate. The extract is washed with water, followed by saturated sodium chloride solution and then it is dried over sodium sulfate. The dried extract is concentrated to dryness iji vacuo to give the crude product.
The procedure above is repeated, except that the di-(methylsulphonyloxy)methane used therein is replaced by an equimolar amount of (1) di(isobutylsulfonvloxy)methane, (2) di(benzenesulfonyloxy)methane and (3) di(4-toluenesulfonyl-cxy)methane. This affords: (1) isobutylsulfonyloxymethvl penicillanate 1,1-dioxide, (2) benzenesulfonyloxymethyl penicillanate 1,1-dioxide, and (3) 4-toluenesulfonyloxymethyl penicillanate 1,1-dioxide, respectively.

Claims (2)

c la ims;
1. A compound of the formula 0 0 0 -o-ch2-x 0 wherein X is selected from the group consisting of alkyl sulfonyloxy having from one to four carbons, benzenesul-fonyloxy and toluene-sulfonyloxy.
2. The compound according to claim 1, wherein X is methylsulfonyloxy. JULY, 1983 EXECUTIVE 27, Clyde Road, Ballsbridge, Dublin 4. AGENTS FOR THE APPLICANTS.
IE1563/83A 1979-05-16 1980-05-15 Penicillanic acid derivatives IE49893B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/039,539 US4244951A (en) 1979-05-16 1979-05-16 Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE1007/80A IE49892B1 (en) 1979-05-16 1980-05-15 Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide

Publications (2)

Publication Number Publication Date
IE831563L true IE831563L (en) 1980-11-16
IE49893B1 IE49893B1 (en) 1986-01-08

Family

ID=26319027

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1563/83A IE49893B1 (en) 1979-05-16 1980-05-15 Penicillanic acid derivatives

Country Status (1)

Country Link
IE (1) IE49893B1 (en)

Also Published As

Publication number Publication date
IE49893B1 (en) 1986-01-08

Similar Documents

Publication Publication Date Title
GB2081269A (en) Penicillanic acid derivatives
CH645902A5 (en) BETA LACTAM INTERMEDIATE CONNECTIONS AND METHOD FOR THE PRODUCTION THEREOF.
CH620216A5 (en)
DE2110387C3 (en) Process for the preparation of cephalosporin compounds
PL127858B1 (en) Process for preparing 3-iodomethylcephalosporins
SE446536B (en) PROCEDURE FOR PREPARING UNSATURED DERIVATIVES OF 7-ACYLAMIDO-3-CEFEM-4-CARBOXYLIC ACID
GB2076801A (en) alpha , beta -Disubstituted Acrylamido Cephalosporins
NO147916B (en) PROCEDURE FOR THE PREPARATION OF 3-METHYLENE-CEPHALOSPORINE COMPOUNDS.
US4217450A (en) Imidazoledicarboxylic acid substituted cephalosporin derivatives
DE60020869T2 (en) A PROCESS FOR THE PRODUCTION OF HIGH-PURITY CEFPODOXIM PROXETIL
EP0185221B1 (en) Process for the preparation of aminothiazolylacetic-acid derivatives
US4008229A (en) Halo substituted β-lactam antibiotics
IE831563L (en) Penicillins
US4297279A (en) Imidazoledicarboxylic acid derivative
US3928333A (en) Process for the preparation of 3 cephalosporin esters
KR870001363B1 (en) Process for preparing lactam derivatives
CH637135A5 (en) Cephalosporin derivatives and a process for their preparation
GB2195334A (en) 1-Methanesulfonyloxy-6-trifluoromethyl-1H-benzotriazole and its use in preparing cephalosporin derivatives
EP0117872A1 (en) Process for preparing cephalosporin compounds
US4316842A (en) Penicillin intermediates
US4446069A (en) Process for the preparation of β-lactam antibiotics
CA1201433A (en) Penicillin derivatives and process for preparation of the same
US3956291A (en) 7-Thioacetamido cephalosporanic acid derivatives
US4866169A (en) 3-substituted-8-oxo-7-substituted-thioxomethylamino-5-thia-1-azabicyclo-(4.2.0)oct-2-ene-2-carboxylic acid, diphenylmethyl esters
KR20230135108A (en) Method for producing 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one

Legal Events

Date Code Title Description
MK9A Patent expired